Benjamin Toll
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Benjamin Toll
Jun 23, 2024, 01:56 |
Insight
Benjamin Toll: Factors contributing to differences in cervical cancer screening
Benjamin Toll, Professor at Medical University of South Carolina, shared on X/Twitter: "Interesting article in…
Jun 16, 2024, 16:07 |
Insight
Outcomes From More Than 1 Million People Screened for Lung Cancer
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Jun 16, 2024, 03:34 |
Blog
Benjamin Toll: AACR-AstraZeneca Breast Cancer Research Fellowship for Endocrine Therapy Research
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on X…
Jun 8, 2024, 07:23 |
Opinion
Benjamin Toll: Interesting study about nausea prevention with olanzapine
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
Apr 6, 2024, 08:50 |
Blog
Benjamin Toll: For colleagues attending the AACR, we have a Session with the FDA Center for Tobacco Products
Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on…
All:
5
Posts:
1 - 10
Career Journey to President and CEO - OncoInfluencers
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Facebook
RSS Feed
Twitter
Linkedin
Youtube